Evidence map›Paper›PMID 34445052›Full record

ArticleNutrients2021

Dietary Selenium Deficiency Partially Mimics the Metabolic Effects of Arsenic.

Christopher M Carmean, Mizuho Mimoto, Michael Landeche, Daniel Ruiz, Bijoy Chellan, Lidan Zhao, Margaret C Schulz, Alexandra M Dumitrescu, Robert M Sargis

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Christopher M CarmeanDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
Mizuho MimotoSection of Endocrinology, Diabetes and Metabolism, University of Chicago, Chicago, IL 60637, USA.
Michael LandecheDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
Daniel RuizCommittee on Molecular Metabolism and Nutrition, University of Chicago, Chicago, IL 60637, USA.
Bijoy ChellanDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
Lidan ZhaoDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
Margaret C SchulzDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
Alexandra M DumitrescuSection of Endocrinology, Diabetes and Metabolism, University of Chicago, Chicago, IL 60637, USA.
Robert M SargisDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
University of Illinois Chicago · USUniversity of Chicago · US

Funding

Pilot and Feasibility ProgramP30DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI RONALD N COHEN · 2013 to 2026
$20.9M
Pilot Program CoreP30ES027792 · NIEHS · UNIVERSITY OF CHICAGO · PI Gokhan M. Mutlu, Gail S Prins · 2017 to 2026
$13.6M
University of Chicago Initiative for Maximizing Student Development (IMSD) - Renewal 01R25GM109439 · NIGMS · UNIVERSITY OF CHICAGO · PI SCHWARTZ, NANCY B · 2014 to 2023
$5.7M
Selenoproteins in Arsenic-Induced Metabolic DysfunctionR01ES028879 · NIEHS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SARGIS, ROBERT M · 2018 to 2022
$2.7M
Mouse Sbp2 deficiency models the multi-system syndrome of human SBP2 defectsR01DK110322 · NIDDK · UNIVERSITY OF CHICAGO · PI DUMITRESCU, ALEXANDRA MIHAELA · 2016 to 2020
$1.8M
Protection against Arsenic-Induced Neurologic Defects by Brain DHA EnrichmentR21ES030884 · NIEHS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SARGIS, ROBERT M · 2019 to 2020
$440k
American Diabetes Association 1-17-JDF-033NIDDK NIH HHS P30 DK020595NIDDK NIH HHS R01 DK110322NIEHS NIH HHS P30 ES027792NIEHS NIH HHS R01 ES028879NIEHS NIH HHS R21 ES030884NIGMS NIH HHS R25 GM109439NIH HHS P30 ES027792NIH HHS R01 ES028879NIH HHS R21 ES030884
6 · The paper itself

Abstract

Chronic arsenic exposure via drinking water is associated with diabetes in human pop-ulations throughout the world. Arsenic is believed to exert its diabetogenic effects via multiple mechanisms, including alterations to insulin secretion and insulin sensitivity. In the past, acute arsenicosis has been thought to be partially treatable with selenium supplementation, though a potential interaction between selenium and arsenic had not been evaluated under longer-term exposure models. The purpose of the present study was to explore whether selenium status may augment arsenic's effects during chronic arsenic exposure. To test this possibility, mice were exposed to arsenic in their drinking water and provided ad libitum access to either a diet replete with selenium (Control) or deficient in selenium (SelD). Arsenic significantly improved glucose tolerance and decreased insulin secretion and β-cell function in vivo. Dietary selenium deficiency resulted in similar effects on glucose tolerance and insulin secretion, with significant interactions between arsenic and dietary conditions in select insulin-related parameters. The findings of this study highlight the complexity of arsenic's metabolic effects and suggest that selenium deficiency may interact with arsenic exposure on β-cell-related physiological parameters.

Indexed as

Insulin ResistanceAnimalsArsenitesBiomarkersBlood GlucoseDeficiency DiseasesDietDisease Models, AnimalInsulinInsulin-Secreting CellsMaleMiceMice, Inbred C57BLSeleniumSodium CompoundsArsenitesBiomarkersBlood GlucoseInsulinSeleniumsodium arseniteSodium Compoundsarsenicdietary interventionendocrine-disrupting chemicalsglucose toleranceinsulin secretionmetabolismmetalsmouse modelnutritionselenium

Identifiers

PMID34445052
PMCPMC8398803
OpenAlexW3193912110

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.